DE112004002232D2 - Pharmazeutischer Wirkstoff gegen Brustkrebs - Google Patents

Pharmazeutischer Wirkstoff gegen Brustkrebs

Info

Publication number
DE112004002232D2
DE112004002232D2 DE112004002232T DE112004002232T DE112004002232D2 DE 112004002232 D2 DE112004002232 D2 DE 112004002232D2 DE 112004002232 T DE112004002232 T DE 112004002232T DE 112004002232 T DE112004002232 T DE 112004002232T DE 112004002232 D2 DE112004002232 D2 DE 112004002232D2
Authority
DE
Germany
Prior art keywords
breast cancer
pharmaceutical agent
agent against
against breast
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE112004002232T
Other languages
English (en)
Inventor
Dirk Weickmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PATENTPOOL TRUST GMBH, 80331 MUENCHEN, DE
Original Assignee
Toximed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toximed GmbH filed Critical Toximed GmbH
Publication of DE112004002232D2 publication Critical patent/DE112004002232D2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE112004002232T 2003-09-08 2004-09-07 Pharmazeutischer Wirkstoff gegen Brustkrebs Expired - Fee Related DE112004002232D2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10341307A DE10341307A1 (de) 2003-09-08 2003-09-08 Pharmarzeutischer Wirkstoff gegen Brustkrebs
PCT/DE2004/001988 WO2005023276A1 (de) 2003-09-08 2004-09-07 Pharmarzeutischer wirkstoff gegen brustkrebs

Publications (1)

Publication Number Publication Date
DE112004002232D2 true DE112004002232D2 (de) 2006-07-27

Family

ID=34223451

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10341307A Withdrawn DE10341307A1 (de) 2003-09-08 2003-09-08 Pharmarzeutischer Wirkstoff gegen Brustkrebs
DE112004002232T Expired - Fee Related DE112004002232D2 (de) 2003-09-08 2004-09-07 Pharmazeutischer Wirkstoff gegen Brustkrebs

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE10341307A Withdrawn DE10341307A1 (de) 2003-09-08 2003-09-08 Pharmarzeutischer Wirkstoff gegen Brustkrebs

Country Status (3)

Country Link
EP (1) EP1699472A1 (de)
DE (2) DE10341307A1 (de)
WO (1) WO2005023276A1 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1120007C (zh) * 2000-10-23 2003-09-03 蔡一青 一种治疗乳腺疾病的药物
CN1215862C (zh) * 2002-11-04 2005-08-24 周宝义 一种治疗恶性肿瘤的中药饮液及制备方法

Also Published As

Publication number Publication date
EP1699472A1 (de) 2006-09-13
DE10341307A1 (de) 2005-03-31
WO2005023276A1 (de) 2005-03-17

Similar Documents

Publication Publication Date Title
DE502004003234D1 (de) Gegen missbrauch gesicherte darreichungsform
DE502004004205D1 (de) Gegen missbrauch gesicherte darreichungsform
DE602004017700D1 (de) Transmukosen verabreichung
DE602004025366D1 (de) Koaxialen Katheter
DK1545662T3 (da) Lægemiddelindgivelsessystem
FI20031763A0 (fi) Eetteröintimenetelmä
DK2266500T3 (da) Tredimensionel vævstruktur
DE602004031733D1 (de) Medizinischer leitungsadapter
EE05505B1 (et) Personaalne teraapiasektsioon
DE602005007873D1 (de) Röntgensichtbare arzneimittelabgabevorrichtung
DE602006013094D1 (de) Krebsmittel
DK1587478T3 (da) Farmaceutisk sammensætning
DK1597171T3 (da) Terapeutisk mikroskum
FI20031750A0 (fi) Mammografialaite
DE502004003840D1 (de) Röntgengerät
DE112004001618D2 (de) Pharmazeutischer Wirkstoff gegen Tumorerkrankungen
DE602004022810D1 (de) Mehrdosis-inhalator
NO20063114L (no) Enoxaparin for behandling av cancer
DE50304722D1 (de) Fungizide Wirkstoffkombinationen
IS8227A (is) Lyf
NO20034952D0 (no) Farmasöytiske forbindelser
DK1618130T3 (da) Terapeutisk cancervaccine
DE60232228D1 (de) Mammakarzinomdetektor
DE112004002232D2 (de) Pharmazeutischer Wirkstoff gegen Brustkrebs
DE112004001429D2 (de) Pharmazeutischer Wirkstoff

Legal Events

Date Code Title Description
8127 New person/name/address of the applicant

Owner name: PATENTPOOL TRUST GMBH, 80331 MUENCHEN, DE

8139 Disposal/non-payment of the annual fee